go-v.orgdoi

Higher Plasma Fibrinogen Levels are Associated with Malignant Phenotype and Worse Survival in Patients with Glioblastomas

Pengfei Wang, Zhe Meng, Hongwang Song, Kun Yao, Zejun Duan, Shouwei Li, Changxiang Yan · Journal of Cancer · 2018

  • DOI 10.7150/jca.24714
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2018

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2018

Abstract

Preoperative plasma fibrinogen levels were associated with poor clinical outcomes in malignancies.There were few data about the prognostic value of plasma fibrinogen in glioblastomas (GBMs).The objective of our study was to investigate the association between fibrinogen and patients' clinicopathological factors and overall survival (OS).From 2008 to 2016, 315 patients with GBMs who had a surgical treatment at our institute, were retrospectively involved in this study.IDH (isocitrate dehydrogenase) mutations and ATRX (alpha thalassemia/mental retardation syndrome X-linked) loss were detected with IHC (Immunohistochemistry).The preoperative plasma fibrinogen levels ranged from 1.00 to 5.22 g/L, with a mean of were 2.57 g/L.There were increased levels of plasma fibrinogen in patients aged ≥ 65 years, secondary GBMs, IDH mutation (p = 0.033) and ATRX loss (p = 0.040).Moreover, the plasma fibrinogen level was the highest in the subtype of IDH-1 R132H wildtype -ATRX expression, which showed a shorter OS compared to the group of IDH-1 R132H mut and IDH-1 R132H wildtype -ATRX loss (p = 0.001, log-rank test).ROC curves for fibrinogen and IDH-1 R132H wildtype -ATRX expression was also plotted, and indicated a potential diagnostic value of fibrinogen in molecular pathology.Univariate analysis found that younger age, higher KPS (Karnofsky Performance Score), gross total resection, complete chemoradiotherapy, IDH-1 R132H mutations and lower levels of fibrinogen were associated with favorable outcomes.Multivariate analysis proved that chemoradiotherapy, IDH-1 R132H and fibrinogen were independent prognostic factors.In conclusion, plasma fibrinogen could predict clinical outcome and molecular subtype in GBMs.

Open the resolved locator · 10.7150/jca.24714

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 15:37 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v09p2024.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.